Orgenesis Stock Net Income
| ORGS Stock | USD 0.15 0.23 60.53% |
Fundamental analysis of Orgenesis allows traders to better anticipate movements in Orgenesis' stock price by examining its financial health and performance throughout various phases of its business cycle.
Orgenesis |
Orgenesis Company Net Income Analysis
Orgenesis' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Orgenesis Net Income | (64.92 M) |
Most of Orgenesis' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orgenesis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Orgenesis reported net income of (64.92 Million). This is 119.02% lower than that of the Biotechnology sector and 192.68% lower than that of the Health Care industry. The net income for all United States stocks is 111.37% higher than that of the company.
Orgenesis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orgenesis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Orgenesis could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics of similar companies.Orgenesis is currently under evaluation in net income category among its peers.
Orgenesis Fundamentals
| Return On Equity | -7.27 | |||
| Return On Asset | -0.3 | |||
| Operating Margin | (16.54) % | |||
| Current Valuation | 23.01 M | |||
| Shares Outstanding | 4.77 M | |||
| Shares Owned By Insiders | 21.16 % | |||
| Shares Owned By Institutions | 4.54 % | |||
| Number Of Shares Shorted | 56.25 K | |||
| Price To Earning | 7.52 X | |||
| Price To Book | 1.26 X | |||
| Price To Sales | 15.21 X | |||
| Revenue | 530 K | |||
| Gross Profit | 36.02 M | |||
| EBITDA | (54.07 M) | |||
| Net Income | (64.92 M) | |||
| Cash And Equivalents | 2.3 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 22.62 M | |||
| Debt To Equity | 0.64 % | |||
| Current Ratio | 1.57 X | |||
| Book Value Per Share | (3.30) X | |||
| Cash Flow From Operations | (14.84 M) | |||
| Short Ratio | 2.39 X | |||
| Earnings Per Share | (8.00) X | |||
| Target Price | 6.0 | |||
| Number Of Employees | 146 | |||
| Beta | 1.21 | |||
| Market Capitalization | 10.07 M | |||
| Total Asset | 14.55 M | |||
| Retained Earnings | (176.62 M) | |||
| Working Capital | (12.33 M) | |||
| Current Asset | 5.29 M | |||
| Current Liabilities | 14.92 M | |||
| Net Asset | 14.55 M |
About Orgenesis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Orgenesis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orgenesis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orgenesis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orgenesis Pink Sheet Analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.